Evidence map›Paper›PMID 34079337›Full record

ArticlePharmacogenomics and personalized medicine2021

Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study.

Concetta Cafiero, Felice Rosapepe, Raffaele Palmirotta, Agnese Re, Maria Pia Ottaiano, Giulio Benincasa, Romina Perone, Elisa Varriale, Gerardo D'Amato, Andrea Cacciamani and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 7 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 7 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Frontiers in genetics · 2022
    Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors?Current issues in molecular biology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Concetta Cafiero *Medical Oncology, SG Moscati Hospital, Taranto, Italy.
Felice Rosapepe *Cardiothoracic Surgery Department, Pineta Grande Hospital, Castelvolturno, CE, Italy.
Raffaele Palmirotta *Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy.ORCID 0000-0002-9401-7377
Agnese ReCatholic University of Sacred Heart, Rome, Italy.ORCID 0000-0003-0929-6568
Maria Pia OttaianoDepartment of Molecular Medicine and Medical Biotechnology, University of Federico II, Naples, Italy.
Giulio BenincasaDepartment of Clinical Pathology and Molecular Biology, Pineta Grande Hospital, Castel Volturno, CE, Italy.ORCID 0000-0002-9060-2915
Romina PeroneAnesthesiology Department, Pineta Grande Hospital, Castelvolturno, CE, Italy.
Elisa VarrialeUOS Oncology, Fatebenefratelli Hospital, Naples, Italy.
Gerardo D'AmatoEndocrine and Metabolic Surgery, A Gemelli Polyclinic Foundation, Rome, Italy.
Andrea CacciamaniResearch Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy.ORCID 0000-0003-1793-9842
Alessandra MiceraResearch Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy.
Salvatore PiscontiMedical Oncology, SG Moscati Hospital, Taranto, Italy.
Villa Pineta Hospital · ITAzienda Ospedaliera S.Giuseppe Moscati · ITFondazione G.B. Bietti · ITAgostino Gemelli University Polyclinic · ITFatebenefratelli Hospital · ITFederico II University Hospital · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe renin-angiotensin-aldosterone system (RAAS), a metabolic cascade regulating pressure and circulating blood volume, has been considered the main system involved in the pathogenesis of severe lung injury and organs decline in COVID-19 patients. The angiotensin I-converting enzyme (

methodsIn this pilot study, the frequencies of six polymorphisms in the

resultsThus, we have identified that rs2074192 (

conclusionThis study provides evidence that analysis of RAAS polymorphisms could be considered the key point in understanding and predicting the SARS-CoV-2 course infection.

Indexed as

ACEAGTAGTR1asymptomaticCOVID-19polymorphismsRAASSARS-CoV-2

Identifiers

PMID34079337
PMCPMC8166347
OpenAlexW3164603853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.